In conclusion, this study showed that in GH deficient patients with hypochondroplasia, a standard dose of GH treatment was found to be sufficient to reach an increase in height just above 0.5 SD in the first year, which is acceptable, but not sufficient for the patients to achieve a sufficient increment in their final height. This evidence concerns the gene GH1 and hypochondroplasia.